68 related articles for article (PubMed ID: 26294210)
1. The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.
Bartolini A; Di Paolo D; Noghero A; Murgia D; Sementa AR; Cilli M; Pasqualini R; Arap W; Bussolino F; Ponzoni M; Pastorino F; Marchiò S
Cancer Res; 2015 Oct; 75(20):4265-71. PubMed ID: 26294210
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
Kanda M; Shimizu D; Sawaki K; Nakamura S; Umeda S; Miwa T; Tanaka H; Tanaka C; Hayashi M; Iguchi Y; Yamada S; Katsuno M; Kodera Y
Mol Cancer; 2020 Aug; 19(1):131. PubMed ID: 32847597
[TBL] [Abstract][Full Text] [Related]
3. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
5. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth.
Lamers F; Schild L; den Hartog IJ; Ebus ME; Westerhout EM; Ora I; Koster J; Versteeg R; Caron HN; Molenaar JJ
Eur J Cancer; 2012 Nov; 48(16):3093-103. PubMed ID: 22366560
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the pentraxin family: the new entry PTX4.
Martinez de la Torre Y; Fabbri M; Jaillon S; Bastone A; Nebuloni M; Vecchi A; Mantovani A; Garlanda C
J Immunol; 2010 May; 184(9):5055-64. PubMed ID: 20357257
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting of neuroblastoma with a novel p16INK4a transporter system.
Kawaguchi T; Yoshikawa K; Kawamoto K; Yoshimura K; Oshige H; Asai A
Int J Oncol; 2014 Jun; 44(6):1879-85. PubMed ID: 24714808
[TBL] [Abstract][Full Text] [Related]
8. Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons.
Pelkey KA; Barksdale E; Craig MT; Yuan X; Sukumaran M; Vargish GA; Mitchell RM; Wyeth MS; Petralia RS; Chittajallu R; Karlsson RM; Cameron HA; Murata Y; Colonnese MT; Worley PF; McBain CJ
Neuron; 2015 Mar; 85(6):1257-72. PubMed ID: 25754824
[TBL] [Abstract][Full Text] [Related]
9. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
10. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
Rogers DA; Schor NF
Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.
Ehrlich D; Wang B; Lu W; Dowling P; Yuan R
J Hematol Oncol; 2014 Dec; 7():91. PubMed ID: 25523825
[TBL] [Abstract][Full Text] [Related]
12. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
13. No association between the neuronal pentraxin II gene polymorphism and autism.
Marui T; Koishi S; Funatogawa I; Yamamoto K; Matsumoto H; Hashimoto O; Ishijima M; Nanba E; Nishida H; Sugiyama T; Kasai K; Watanabe K; Kano Y; Kato N; Sasaki T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):940-3. PubMed ID: 17408830
[TBL] [Abstract][Full Text] [Related]
14. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
15. C1QL3 promotes cell-cell adhesion by mediating complex formation between ADGRB3/BAI3 and neuronal pentraxins.
Sticco MJ; Peña Palomino PA; Lukacsovich D; Thompson BL; Földy C; Ressl S; Martinelli DC
FASEB J; 2021 Jan; 35(1):e21194. PubMed ID: 33337553
[TBL] [Abstract][Full Text] [Related]
16. Genistein demethylates the promoter of CHD5 and inhibits neuroblastoma growth in vivo.
Li H; Xu W; Huang Y; Huang X; Xu L; Lv Z
Int J Mol Med; 2012 Nov; 30(5):1081-6. PubMed ID: 22960751
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma.
Khan T; Hixon JA; Stauffer JK; Lincoln E; Back TC; Brenner J; Lockett S; Nagashima K; Powell D; Wigginton JM
J Natl Cancer Inst; 2006 Feb; 98(3):190-202. PubMed ID: 16449679
[TBL] [Abstract][Full Text] [Related]
18. Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains.
Gilgès D; Vinit MA; Callebaut I; Coulombel L; Cacheux V; Romeo PH; Vigon I
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):49-59. PubMed ID: 11062057
[TBL] [Abstract][Full Text] [Related]
19. Schwann cell-conditioned medium inhibits angiogenesis.
Huang D; Rutkowski JL; Brodeur GM; Chou PM; Kwiatkowski JL; Babbo A; Cohn SL
Cancer Res; 2000 Nov; 60(21):5966-71. PubMed ID: 11085514
[TBL] [Abstract][Full Text] [Related]
20. The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma.
Huang P; Kishida S; Cao D; Murakami-Tonami Y; Mu P; Nakaguro M; Koide N; Takeuchi I; Onishi A; Kadomatsu K
Cancer Res; 2011 Apr; 71(8):2938-48. PubMed ID: 21349947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
